According to our latest research offering “Global Contract Manufacturing Market Analysis”, the contract manufacturing industry pertaining to the pharma industry will grow on the back of cost cutting measures, which are being adopted globally. Besides, the industry will gain momentum by the rising demands of the biopharmaceutical products. Biopharmaceutical products have been more efficient in both, prevention and cure of various diseases, and are hence being preferred over the normal chemical based drugs. However, the capital intensive nature of this particular segment has caused a big stir in the industry. As the pharma majors are looking to outsource the production of the biopharmaceutical products, the contract manufacturing industry is expected to grow at a CAGR of 11% till 2013.
To provide a clear view of the potential held by the market at the global level, we have segregated the market in terms of developed and developing contract manufacturing countries. Within each segment, there are numerous countries, which have been covered in detail, including an overview of the key players and their field of specialization in pharma manufacturing. Besides, the report includes the export figures of pharma products in some prominent contract manufacturing destinations.
Hiç yorum yok:
Yorum Gönder